What Two Sigma Advisers LP changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$0
$7.0bn at Q2 2013
Positions
0
2,136 at Q2 2013
Top ten weight
n.a.
19% at Q2 2013
Typical quarterly turnover
about 26%
Estimated from share changes
- Q2 2013: $7.0bn
- Q3 2013: $8.4bn
- Q4 2013: $10.4bn
- Q1 2014: $11.0bn
- Q2 2014: $12.8bn
- Q3 2014: $13.3bn
- Q4 2014: $12.9bn
- Q1 2015: $13.6bn
- Q2 2015: $13.4bn
- Q3 2015: $15.9bn
- Q4 2015: $16.8bn
- Q1 2016: $17.9bn
- Q2 2016: $19.7bn
- Q3 2016: $23.5bn
- Q4 2016: $26.1bn
- Q1 2017: $30.5bn
- Q2 2017: $30.3bn
- Q3 2017: $35.3bn
- Q4 2017: $37.1bn
- Q1 2018: $36.9bn
- Q2 2018: $37.2bn
- Q3 2018: $41.0bn
- Q4 2018: $36.6bn
- Q1 2019: $39.7bn
- Q2 2019: $40.2bn
- Q3 2019: $40.9bn
- Q4 2019: $43.1bn
- Q1 2020: $26.1bn
- Q2 2020: $34.0bn
- Q3 2020: $35.0bn
- Q4 2020: $37.4bn
- Q1 2021: $36.4bn
- Q2 2021: $37.9bn
- Q3 2021: $38.6bn
- Q4 2021: $39.9bn
- Q1 2022: $37.6bn
- Q2 2022: $35.3bn
- Q3 2022: $34.5bn
- Q4 2022: $35.8bn
- Q1 2023: $38.8bn
- Q2 2023: $39.3bn
- Q3 2023: $39.0bn
- Q4 2023: $42.7bn
- Q1 2024: $43.2bn
- Q2 2024: $44.8bn
- Q3 2024: $42.7bn
- Q4 2024: $43.2bn
- Q1 2025: $44.4bn
- Q2 2025: $48.8bn
- Q3 2025: $50.0bn
- Q4 2025: $51.4bn
- Q1 2026: $0
- Q2 2026: $0
- Q2 2013: 19%
- Q3 2013: 14%
- Q4 2013: 14%
- Q1 2014: 13%
- Q2 2014: 13%
- Q3 2014: 10%
- Q4 2014: 10%
- Q1 2015: 9%
- Q2 2015: 9%
- Q3 2015: 9%
- Q4 2015: 10%
- Q1 2016: 11%
- Q2 2016: 12%
- Q3 2016: 10%
- Q4 2016: 9%
- Q1 2017: 9%
- Q2 2017: 10%
- Q3 2017: 10%
- Q4 2017: 9%
- Q1 2018: 8%
- Q2 2018: 9%
- Q3 2018: 10%
- Q4 2018: 10%
- Q1 2019: 10%
- Q2 2019: 11%
- Q3 2019: 12%
- Q4 2019: 12%
- Q1 2020: 12%
- Q2 2020: 14%
- Q3 2020: 13%
- Q4 2020: 12%
- Q1 2021: 14%
- Q2 2021: 13%
- Q3 2021: 13%
- Q4 2021: 13%
- Q1 2022: 14%
- Q2 2022: 13%
- Q3 2022: 14%
- Q4 2022: 14%
- Q1 2023: 12%
- Q2 2023: 14%
- Q3 2023: 16%
- Q4 2023: 17%
- Q1 2024: 17%
- Q2 2024: 18%
- Q3 2024: 17%
- Q4 2024: 20%
- Q1 2025: 18%
- Q2 2025: 19%
- Q3 2025: 19%
- Q4 2025: 19%
- Q1 2026: 0%
- Q2 2026: 0%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Nvidia Corp(NVDA) | Q3 2016 | $1.7bnQ4 2025 | Soldlast listed Q4 2025 | |
| Apple Inc(AAPL) | Q3 2013 | $1.6bnQ4 2025 | Soldlast listed Q4 2025 | |
| Microsoft Corp(MSFT) | Q3 2014 | $1.5bnQ3 2025 | Soldlast listed Q4 2025 | |
| Amazon Com Inc(AMZN) | Q1 2015 | $1.1bnQ4 2025 | Soldlast listed Q4 2025 | |
| Alphabet Inc(GOOGL)Capital Stock Class A | Q4 2015 | $801mQ2 2025 | Soldlast listed Q4 2025 | |
| JPMorgan Chase & Co(JPM) | Q2 2013 | $769mQ3 2025 | Soldlast listed Q4 2025 | |
| Facebook Inc A(META)Class A | Q3 2014 | $726mQ4 2024 | Soldlast listed Q4 2025 | |
| Mastercard Inc(MA)Class A | Q3 2014 | $701mQ4 2025 | Soldlast listed Q4 2025 |
Quarter by quarter
Q1 2024: $43.2bn across 2,431 positions
Against Q4 2023: 247 new, 843 added to, 1,318 trimmed, 295 sold out, across all 2,431 positions.
Turnover about 23% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Humana Inc (HUM)+$336m
- Facebook Inc A (META)+$289m
- Pfizer Inc (PFE)+$289m
- NIKE Inc (NKE)+$279m
- Gilead Sciences Inc (GILD)+$277m
- Pepsico Inc (PEP)+$252m
- Abbott Labs (ABT)+$226m
- Lilly Eli & Co (LLY)+$211m
Largest reductions
- Carnival Corp (CCL)-$261m
- Merck & Co Inc New (MRK)-$240m
- Amgen Inc (AMGN)-$234m
- Starbucks Corp (SBUX)-$209m
- Johnson & Johnson (JNJ)-$208m
- Emerson Elec Co (EMR)-$200m
- Colgate Palmolive Co (CL)-$191m
- Roku Inc (ROKU)-$190m
Opened
- Wal-mart Stores Inc (WMT)$461m
Sold out
- Rivian Automotive Inc (RIVN)was $279m
- CVS Caremark Corporation (CVS)was $253m
- Sofi Technologies Inc (SOFI)was $116m
- iShares Inc (EWZ)was $58m
- Prudential Finl Inc (PRU)was $41m
- Deutsche Bank AG (DB)was $40m
- Advanced Micro Devices Inc (AMD)was $35m
- American Airlines Group Inc (AAL)was $31m
Largest positions, Q1 2024
The largest 25 of 2,431 reported positions; the largest 500 carry 89.8% of the reported value.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Apple Inc (AAPL) | $1.1bn | 2.6% | Added |
| Microsoft Corp (MSFT) | $1.0bn | 2.4% | Trimmed |
| Amazon Com Inc (AMZN) | $863m | 2.0% | Trimmed |
| Nvidia Corp (NVDA) | $849m | 2.0% | Trimmed |
| Facebook Inc A (META) | $686m | 1.6% | Added |
| Alphabet Inc (GOOGL) | $686m | 1.6% | Trimmed |
| Visa Inc (V) | $539m | 1.2% | Trimmed |
| PayPal HLDGS Inc (PYPL) | $498m | 1.2% | Trimmed |
| Mastercard Inc (MA) | $494m | 1.1% | Added |
| Netflix Inc (NFLX) | $493m | 1.1% | Trimmed |
| Micron Technology Inc (MU) | $491m | 1.1% | Trimmed |
| Bristol Myers Squibb Co (BMY) | $485m | 1.1% | Added |
| Crowdstrike HLDGS Inc (CRWD) | $471m | 1.1% | Added |
| Lilly Eli & Co (LLY) | $468m | 1.1% | Added |
| Wal-mart Stores Inc (WMT) | $461m | 1.1% | New |
| Qualcomm Inc (QCOM) | $385m | 0.9% | Trimmed |
| General Motors Co (GM) | $381m | 0.9% | Trimmed |
| Pfizer Inc (PFE) | $376m | 0.9% | Added |
| Gilead Sciences Inc (GILD) | $372m | 0.9% | Added |
| Pinterest Inc (PINS) | $369m | 0.9% | Trimmed |
| Lockheed Martin Corp (LMT) | $365m | 0.8% | Added |
| Humana Inc (HUM) | $364m | 0.8% | Added |
| Doordash Inc (DASH) | $330m | 0.8% | Trimmed |
| NIKE Inc (NKE) | $309m | 0.7% | Added |
| Lauder Estee Cos Inc (EL) | $300m | 0.7% | Trimmed |
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Two Sigma Advisers LP | $0 | 13F-HR | |
| Q1 2026 | Two Sigma Advisers LP | $0 | 13F-HR | |
| Q4 2025 | Two Sigma Advisers LP | $51.4bn | 13F-HR | |
| Q3 2025 | Two Sigma Advisers LP | $50.0bn | 13F-HR | |
| Q2 2025 | Two Sigma Advisers LP | $48.8bn | 13F-HR | |
| Q1 2025 | Two Sigma Advisers LP | $44.4bn | 13F-HR | |
| Q4 2024 | Two Sigma Advisers LP | $43.2bn | 13F-HR | |
| Q3 2024 | Two Sigma Advisers LP | $42.7bn | 13F-HR | |
| Q2 2024 | Two Sigma Advisers LP | $44.8bn | 13F-HR | |
| Q1 2024 | Two Sigma Advisers LP | $43.2bn | 13F-HR | |
| Q4 2023 | Two Sigma Advisers LP | $42.7bn | 13F-HR | |
| Q3 2023 | Two Sigma Advisers LP | $39.0bn | 13F-HR | |
| Q2 2023 | Two Sigma Advisers LP | $39.3bn | 13F-HR | |
| Q1 2023 | Two Sigma Advisers LP | $38.8bn | 13F-HR | |
| Q4 2022 | Two Sigma Advisers LP | $35.8bn | 13F-HR | |
| Q3 2022 | Two Sigma Advisers LP | $34.5bn | 13F-HR | |
| Q2 2022 | Two Sigma Advisers LP | $35.3bn | 13F-HR | |
| Q1 2022 | Two Sigma Advisers LP | $37.6bn | 13F-HR | |
| Q4 2021 | Two Sigma Advisers LP | $39.9bn | 13F-HR | |
| Q3 2021 | Two Sigma Advisers LP | $38.6bn | 13F-HR | |
| Q2 2021 | Two Sigma Advisers LP | $37.9bn | 13F-HR | |
| Q1 2021 | Two Sigma Advisers LP | $36.4bn | 13F-HR | |
| Q4 2020 | Two Sigma Advisers LP | $37.4bn | 13F-HR | |
| Q3 2020 | Two Sigma Advisers LP | $35.0bn | 13F-HR | |
| Q2 2020 | Two Sigma Advisers LP | $34.0bn | 13F-HR | |
| Q1 2020 | Two Sigma Advisers LP | $26.1bn | 13F-HR | |
| Q4 2019 | Two Sigma Advisers LP | $43.1bn | 13F-HR | |
| Q3 2019 | Two Sigma Advisers LP | $40.9bn | 13F-HR | |
| Q2 2019 | Two Sigma Advisers LP | $40.2bn | 13F-HR | |
| Q1 2019 | Two Sigma Advisers LP | $39.7bn | 13F-HR | |
| Q4 2018 | Two Sigma Advisers LP | $36.6bn | 13F-HR | |
| Q3 2018 | Two Sigma Advisers LP | $41.0bn | 13F-HR | |
| Q2 2018 | Two Sigma Advisers LP | $37.2bn | 13F-HR | |
| Q1 2018 | Two Sigma Advisers LP | $36.9bn | 13F-HR | |
| Q4 2017 | Two Sigma Advisers LP | $37.1bn | 13F-HR | |
| Q3 2017 | Two Sigma Advisers LP | $35.3bn | 13F-HR | |
| Q2 2017 | Two Sigma Advisers LP | $30.3bn | 13F-HR | |
| Q1 2017 | Two Sigma Advisers LP | $30.5bn | 13F-HR | |
| Q4 2016 | Two Sigma Advisers LP | $26.1bn | 13F-HR | |
| Q3 2016 | Two Sigma Advisers LP | $23.5bn | 13F-HR | |
| Q2 2016 | Two Sigma Advisers LP | $19.7bn | 13F-HR | |
| Q1 2016 | Two Sigma Advisers LP | $17.9bn | 13F-HR | |
| Q4 2015 | Two Sigma Advisers LP | $16.8bn | 13F-HR | |
| Q3 2015 | Two Sigma Advisers LP | $15.9bn | 13F-HR | |
| Q2 2015 | Two Sigma Advisers LP | $13.4bn | 1 | 13F-HR |
| Q1 2015 | Two Sigma Advisers LP | $13.6bn | 1 | 13F-HR |
| Q4 2014 | Two Sigma Advisers LP | $12.9bn | 1 | 13F-HR |
| Q3 2014 | Two Sigma Advisers LP | $13.3bn | 1 | 13F-HR |
| Q2 2014 | Two Sigma Advisers LP | $12.8bn | 1 | 13F-HR |
| Q1 2014 | Two Sigma Advisers LP | $11.0bn | 13F-HR | |
| Q4 2013 | Two Sigma Advisers LP | $10.4bn | 13F-HR | |
| Q3 2013 | Two Sigma Advisers LP | $8.4bn | 13F-HR | |
| Q2 2013 | Two Sigma Advisers LP | $7.0bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More